학술논문

Whole genome sequence analysis of blood lipid levels in >66,000 individuals
Document Type
article
Author
Selvaraj, Margaret SunithaLi, XihaoLi, ZilinPampana, AkhilZhang, David YPark, JosephAslibekyan, StellaBis, Joshua CBrody, Jennifer ACade, Brian EChuang, Lee-MingChung, Ren-HuaCurran, Joanne Ede las Fuentes, Lisade Vries, Paul SDuggirala, RavindranathFreedman, Barry IGraff, MariaelisaGuo, XiuqingHeard-Costa, NancyHidalgo, BerthaHwu, Chii-MinIrvin, Marguerite RKelly, Tanika NKral, Brian GLange, LeslieLi, XiaohuiLisa, MartinLubitz, Steven AManichaikul, Ani WMichael, PreussMontasser, May EMorrison, Alanna CNaseri, TakeO’Connell, Jeffrey RPalmer, Nicholette DPeyser, Patricia AReupena, Muagututia SSmith, Jennifer ASun, XiaoTaylor, Kent DTracy, Russell PTsai, Michael YWang, ZheWang, YuxuanBao, WeiWilkins, John TYanek, Lisa RZhao, WeiArnett, Donna KBlangero, JohnBoerwinkle, EricBowden, Donald WChen, Yii-Der IdaCorrea, AdolfoCupples, L AdrienneDutcher, Susan KEllinor, Patrick TFornage, MyriamGabriel, StaceyGermer, SorenGibbs, RichardHe, JiangKaplan, Robert CKardia, Sharon LRKim, RyanKooperberg, CharlesLoos, Ruth JFViaud-Martinez, Karine AMathias, Rasika AMcGarvey, Stephen TMitchell, Braxton DNickerson, DeborahNorth, Kari EPsaty, Bruce MRedline, SusanReiner, Alexander PVasan, Ramachandran SRich, Stephen SWiller, CristenRotter, Jerome IRader, Daniel JLin, XihongPeloso, Gina MNatarajan, Pradeep
Source
Nature Communications. 13(1)
Subject
Biological Sciences
Biomedical and Clinical Sciences
Genetics
Epidemiology
Health Sciences
Biotechnology
Heart Disease - Coronary Heart Disease
Cardiovascular
Heart Disease
Human Genome
Aetiology
2.1 Biological and endogenous factors
Good Health and Well Being
Alleles
Cholesterol
LDL
Genome-Wide Association Study
Humans
Lipids
Whole Genome Sequencing
NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium
Language
Abstract
Blood lipids are heritable modifiable causal factors for coronary artery disease. Despite well-described monogenic and polygenic bases of dyslipidemia, limitations remain in discovery of lipid-associated alleles using whole genome sequencing (WGS), partly due to limited sample sizes, ancestral diversity, and interpretation of clinical significance. Among 66,329 ancestrally diverse (56% non-European) participants, we associate 428M variants from deep-coverage WGS with lipid levels; ~400M variants were not assessed in prior lipids genetic analyses. We find multiple lipid-related genes strongly associated with blood lipids through analysis of common and rare coding variants. We discover several associated rare non-coding variants, largely at Mendelian lipid genes. Notably, we observe rare LDLR intronic variants associated with markedly increased LDL-C, similar to rare LDLR exonic variants. In conclusion, we conducted a systematic whole genome scan for blood lipids expanding the alleles linked to lipids for multiple ancestries and characterize a clinically-relevant rare non-coding variant model for lipids.